[{"indications": "Indications\u00a0treatment of acute migraine and migraine variants unresponsive to analgesics", "name": "ERGOTAMINE TARTRATE  - ERGOTAMINE TARTRATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.4 Antimigraine drugs", "4.7.4.1 Treatment of acute migraine", "Ergot alkaloids", "ERGOTAMINE TARTRATE"], "cautions": "Cautions\u00a0risk of peripheral vasospasm (see below); elderly; dependence (see Ergot Alkaloids above); cardiac\r\ndisease; anaemia; interactions: Appendix 1 (ergot alkaloids)Peripheral vasospasm\u00a0Warn patient\r\nto stop treatment immediately if numbness or tingling of extremities\r\ndevelops and to contact doctor.", "side-effects": "Side-effects\u00a0abdominal pain, nausea, vomiting; dizziness; less commonly diarrhoea, pain and weakness in extremities,\r\ncyanosis, peripheral vasoconstriction, paraesthesia, and hypoaesthesia; rarely intestinal ischaemia, arrhythmias, increased blood\r\npressure, bradycardia, tachycardia, dyspnoea, ergotism (including\r\nabsence of pulse and numbness in extremities), myalgia, rash, and\r\nurticaria; very rarely myocardial ischaemia, myocardial\r\ninfarction, heart-valve fibrosis, and gangrene; constipation, dry\r\nmouth, cerebral ischaemia, thrombosis, drowsiness, sleep disturbances,\r\ntremor, seizures, extrapyramidal effects, anxiety, depression, confusion,\r\nhallucinations, renal artery spasm, urinary retention, blood disorders,\r\nblurred vision, and arthralgia also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3557.htm", "doses": ["Name[Cafergot\u00ae (Alliance) ] adult and child over 12 years, 1\u20132 tablets at onset; max. 4\r\ntablets in 24 hours; not to be repeated at intervals of less than\r\n4 days; max. 8 tablets in one week (but see also notes above)"], "pregnancy": "Pregnancy\u00a0avoid; oxytocic effect on the uterus"}, {"indications": "Indications\u00a0treatment of acute migraine and migraine variants unresponsive to analgesics", "name": "ERGOTAMINE TARTRATE ", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.4 Antimigraine drugs", "4.7.4.1 Treatment of acute migraine", "Ergot alkaloids", "ERGOTAMINE TARTRATE"], "cautions": "Cautions\u00a0risk of peripheral vasospasm (see below); elderly; dependence (see Ergot Alkaloids above); cardiac\r\ndisease; anaemia; interactions: Appendix 1 (ergot alkaloids)Peripheral vasospasm\u00a0Warn patient\r\nto stop treatment immediately if numbness or tingling of extremities\r\ndevelops and to contact doctor.", "side-effects": "Side-effects\u00a0abdominal pain, nausea, vomiting; dizziness; less commonly diarrhoea, pain and weakness in extremities,\r\ncyanosis, peripheral vasoconstriction, paraesthesia, and hypoaesthesia; rarely intestinal ischaemia, arrhythmias, increased blood\r\npressure, bradycardia, tachycardia, dyspnoea, ergotism (including\r\nabsence of pulse and numbness in extremities), myalgia, rash, and\r\nurticaria; very rarely myocardial ischaemia, myocardial\r\ninfarction, heart-valve fibrosis, and gangrene; constipation, dry\r\nmouth, cerebral ischaemia, thrombosis, drowsiness, sleep disturbances,\r\ntremor, seizures, extrapyramidal effects, anxiety, depression, confusion,\r\nhallucinations, renal artery spasm, urinary retention, blood disorders,\r\nblurred vision, and arthralgia also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3560.htm", "doses": ["Name[Migril\u00ae (Wockhardt) ] 1 tablet at onset, followed after 30 minutes by \u00bd\u20131 tablet,\r\nrepeated every 30 minutes if necessary; max. 3 tablets in 24 hours,\r\n4 tablets per attack, 6 tablets in one week (but see also notes above); child not recommended"], "pregnancy": "Pregnancy\u00a0avoid; oxytocic effect on the uterus"}]